Dexcom (DXCM) Current Leases (2019 - 2026)

Dexcom (DXCM) has reported Current Leases for 8 consecutive years, with $20.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Leases fell 11.54% year-over-year to $20.7 million in Q2 2026; TTM through Jun 2026 was $20.7 million, a 11.54% decrease from a year earlier, with the FY2025 full-year figure at $21.6 million, down 4.0% from the prior year.
• Current Leases was $20.7 million for Q2 2026 at Dexcom, up from $20.5 million in the prior quarter.
• Over five years, Current Leases peaked at $23.6 million in Q3 2025 and troughed at $20.5 million in Q4 2022.
• A 5-year average of $21.6 million and a median of $21.4 million in 2022 frame the typical range for Current Leases.
• Across the five-year window, Current Leases advanced 14.84% in 2022 and fell 11.54% in 2026, its largest moves.
• Over 5 years, Current Leases stood at $20.5 million in 2022, then gained by 2.93% to $21.1 million in 2023, then gained by 6.64% to $22.5 million in 2024, then dropped by 4.0% to $21.6 million in 2025, then dropped by 4.17% to $20.7 million in 2026.
• The last three Current Leases figures came in at $20.7 million (Q2 2026), $20.5 million (Q1 2026), and $21.6 million (Q4 2025), per Business Quant data.